The Rise of Contingent Value: CVRs and Earnouts Reshape Life Sciences M&A

Start
Key Takeaways: CVR usage surged from 7 publicly disclosed deals in 2024 to 27 deals in 2025, with some CVRs representing over 70% of total deal value….
By: Foley Hoag LLP
Previous Story

FTC Targets EdTech Data Practices in Final Order Following Major Student Data Breach

Next Story

Darktrace Report Highlights Cyber Threats Against Global Sporting Sector